ePRO and eConsent
Medable for Patients
Medable’s ePRO platform has gone through rigorous user testing, delivering a superior patient experience to optimize engagement and improve data quality
all direct to patient (eSignature, eConsent) and in real time.
patient location, air quality, weather, disease, and crime.
between provider and patient. Patients receive feedback in real time through virtual visits.
Apple Watch, Fitbit, etc.
WiFi scale, Apple Watch, Continuous Glucose Monitor, Bluetooth connected pill bottle, etc.
patients receive recommendations for concerning symptoms and assigned stakeholders receive alerts for specific symptoms or symptom frequency.
to support adherence.
for protocol amendments, modified use of patient data, or new trial opportunities.
Features include: Simple or complex schedules, Image, audio or video capture, Branching for response-based data capture, Data or event-based contingencies, Active tasks: 6 Minute Walk Test, Gait and Balance, Visual Acuity, etc.
Medable’s technology is currently being used by over 750,000 patients across 5 continents. We are the only enterprise cloud purpose built for life sciences with dedicated AI and machine learning. We have experience with registry studies and Phase I-IV clinical trials as well as in the following areas and more.